| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/12/2005 | US6916796 Producing a blunted glycemic response in a diabetic patient by administering pullulan |
| 07/12/2005 | US6916791 Androgen glycosides useful as contraceptives, for increasing muscle mass, and treatment of a hypogonadal disorder, androgen deficiency, sexual dysfunction and osteoporosis |
| 07/09/2005 | CA2452162A1 Diabetogenic epitope from a .alpha./.beta.-gliadin a-ii precursor, .alpha./.beta.-gliadin mm1 precursor or g1b1 |
| 07/07/2005 | WO2005037839A8 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 07/07/2005 | WO2004060369A8 Kynurenine 3-hydroxylase inhibitors for the treatment of diabetes |
| 07/07/2005 | US20050148768 Cobalt-porphyrin complexes and use thereof as an anti-obesity agent |
| 07/07/2005 | US20050148670 Skin disorders; antiinflammatory agents; antiproliferative agents; controlling metabolism; obesity; antilipemic agents; antihistamines |
| 07/07/2005 | US20050148664 therapy of NF-kappaB mediated diseases; mitochondrial diseases; transplantation medicine |
| 07/07/2005 | US20050148656 Carboxylic derivates |
| 07/07/2005 | US20050148636 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 07/07/2005 | US20050148625 Use of estrogen antagonists and estrogen agonists inhibiting pathological conditions |
| 07/07/2005 | US20050148617 Drugs for eating disorders and treating obesity or anxiety with G protein |
| 07/07/2005 | US20050148606 2,6-Dioxo-1,2,3,6-tetrahydropurine derivatives; dipeptidyl peptidase IV inhibitors for diabetes and obesity |
| 07/07/2005 | US20050148591 Tartrate salts of 5,8,14-triazatetracyclo [10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaen and pharmaceutical compositions thereof |
| 07/07/2005 | US20050148584 N-(3-(2-(4-morpholino)ethyloxy)phenyl)-N-{(cis3-(benzylamino)cyclohexyl)methyl}-N'-phenylurea; useful for the treatment of gastrointestinal reflux disorders, eating disorders leading to obesity and irritable bowel syndrome |
| 07/07/2005 | US20050148575 (Di)Azepino[5,4,3-cd]benzothiophenes; poly(ADP-ribose) polymerase (PARP) and glycohydrolase (PARG) inhibitor; antiinflammatory; protects cells, tissue and organs against the ill-effects of reactive free radicals and nitric oxide, and damage following focal ischemia and reperfusion injury |
| 07/07/2005 | US20050148558 Stabilized hydroxyvitamin D |
| 07/07/2005 | US20050148525 Nucleic acid markers |
| 07/07/2005 | US20050148521 Coadministration with non-steroidal antiinflammatory agent allows for lower dosage of cyclophosphamide; side effect reduction; kits |
| 07/07/2005 | US20050148515 Peptidomimetics; determining ability to bind growth hormone secretagogue; ghrelin agonists; appetite stimulation; dietetics |
| 07/07/2005 | US20050148513 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/07/2005 | US20050148504 Cysteine protease inhibitor |
| 07/07/2005 | US20050148497 Method for administering glp-1 molecules |
| 07/07/2005 | US20050148014 Regulation of human P2Y1-like G protein-coupled receptor |
| 07/07/2005 | US20050147695 Method of preventing parturient hypocalcemia in animals and compositions used therein |
| 07/07/2005 | US20050147666 Rapidly disintegrates in the oral cavity without water and has a practical hardness; comprises a water soluble active ingredient, D-mannitol in the form of crystals or fine particles and crospovidone |
| 07/07/2005 | US20050147665 Consisting of eicosapentaenoic acid or derivative, vitamin B 12, folic acid, at a maximum daily dose of 5 mg, and vitamin B6, at a maximum daily dose of 20 mg, and optionally at least one antioxidant; treatment of psychiatric disorders; schizophrenia, Alzheimer's disease, dementia, Parkinson's disease |
| 07/07/2005 | US20050147598 Combining with animal fat, vegetable oil and/or polyol; oxidation resistance; shelf life |
| 07/07/2005 | US20050147592 Correcting underlying genetic defect; delivering heterologous gene encoding metabolic protein causing transduction of cells resulting in expression from transformed cell genetics |
| 07/07/2005 | US20050147577 Composition for pharmaceutical or dietetic use for combating hair loss |
| 07/07/2005 | US20050147567 highly dispersible mixture of drugs and dipeptides or tripeptides, in the form of liquids, aerosols or powders, administered by inhalation |
| 07/07/2005 | DE10356815A1 Use of an angiotensin II receptor antagonist for treating type 2 diabetes or prediabetes, for preventing diabetes or for treating metabolic syndrome and insulin resistance in patients with normal blood pressure |
| 07/07/2005 | CA2550843A1 Novel phenylalanine derivatives |
| 07/07/2005 | CA2550215A1 Diphenylazetidinone derivates possessing cholesterol absorption inhibitory activity |
| 07/07/2005 | CA2549966A1 Drug-containing nanoparticle, process for producing the same and parenterally administered preparation from the nanoparticle |
| 07/07/2005 | CA2549651A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 07/07/2005 | CA2549103A1 Use of a fatty acid composition comprising at least one of epa and dha or any combinations thereof |
| 07/07/2005 | CA2549008A1 Selective peroxisome proliferator activated receptor modulators |
| 07/07/2005 | CA2548410A1 Diphenylazetidinone derivates processing cholesterol absorption inhibitory activity |
| 07/06/2005 | EP1550727A1 Novel macrophage foam cell formation inhibitor fka-25 and p rocess for producing the same |
| 07/06/2005 | EP1550674A1 Chitosan-containing polysaccharide, process for producing the same and use thereof |
| 07/06/2005 | EP1550668A1 Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same |
| 07/06/2005 | EP1550462A1 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 07/06/2005 | EP1550461A1 Remedy for chronic disease |
| 07/06/2005 | EP1550454A1 Extracorporeal photopheresis in combination with anti-TNF treatment |
| 07/06/2005 | EP1549950A1 Methods for identifying glucose uptake modulators |
| 07/06/2005 | EP1549756A2 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 07/06/2005 | EP1549660A2 RNA INTERFERENCE MEDIATED INHIBITION OF GRB2-ASSOCIATED BINDING PROTEIN 2 (GAB2) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 07/06/2005 | EP1549655A2 Substituted bicyclic thiophene derivatives, compostions containing such compounds and methods of use |
| 07/06/2005 | EP1549640A2 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)azetidine-3-carboxylates and 1-((5-aryl-1,2,4-oxadiazol-3-yl)benzyl)pyrrolidine-3-carboxylates as edg receptor agonists |
| 07/06/2005 | EP1549638A1 Indole-3-carboxamides as glucokinase (gk) activators |
| 07/06/2005 | EP1549634A1 Novel substituted indoles |
| 07/06/2005 | EP1549632A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 07/06/2005 | EP1549630A1 Metastable benzoxepne derivatives which can be used in the treatment of dyslipidaemia, atherosclerosis and diabetes, pharmaceutical compositions comprising them and processes for the preparation thereof |
| 07/06/2005 | EP1549625A1 Novel heterocyclic analogs of diphenylethylene compounds |
| 07/06/2005 | EP1549600A1 Ketones |
| 07/06/2005 | EP1549351A1 Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis |
| 07/06/2005 | EP1549348A1 Association between a ppar ligand and an antioxidant agent and use thereof for treating obesity |
| 07/06/2005 | EP1549334A1 A pharmaceutical composition comprising a retro-iverso isomer pettide |
| 07/06/2005 | EP1549319A2 Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of use |
| 07/06/2005 | EP1549309A2 Somatostatin analogue compounds |
| 07/06/2005 | EP1549306A1 Substituted phenylsulfonamide inhibitors of beta amyloid production |
| 07/06/2005 | EP1549296A1 Sustained release formulations of metformin |
| 07/06/2005 | EP1549156A1 Denatured carob flour (dcf) with a low content of soluble tannins and sugars, meant for human consumption and process to obtain it |
| 07/06/2005 | EP1490315A4 Controlling chemical reactions by spectral chemistry and spectral conditioning |
| 07/06/2005 | EP1301187B1 Purine-2,6-diones which are inhibitors of the enzyme dipeptidyl peptidase iv (dpp-iv) |
| 07/06/2005 | EP1244725B1 Amorphous polymeric polyaxial initiators and compliant crystalline copolymers therefrom |
| 07/06/2005 | EP1140145B1 Novel exendin agonist formulations and methods of administration thereof |
| 07/06/2005 | CN1636067A TACIs and BR3 polypeptides and uses thereof |
| 07/06/2005 | CN1636064A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 07/06/2005 | CN1636061A Novel serine protease genes related to DPPIV |
| 07/06/2005 | CN1636021A Preparation and use of solidified oils |
| 07/06/2005 | CN1636009A Partial and full agonists of a1 adenosine receptors |
| 07/06/2005 | CN1636005A Benzothiazinone and benzoxazinone compounds |
| 07/06/2005 | CN1636004A Process for the manufacture of hmg-coa reductase inhibitory mevalonic acid derivatives |
| 07/06/2005 | CN1636003A Vitamin D3 derivatives and remedies using the same |
| 07/06/2005 | CN1636000A 5-substituted arylpyrimidines |
| 07/06/2005 | CN1635911A Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 07/06/2005 | CN1635907A Topical compositions and methods for treatment of adverse effects of ionizing radiation |
| 07/06/2005 | CN1635901A Remodeling and glycoconjugation of peptides |
| 07/06/2005 | CN1635900A Pre-mixes of GLP-1 and basal insulin |
| 07/06/2005 | CN1635894A Dosage form for treatment of diabetes mellitus |
| 07/06/2005 | CN1635885A Improvement of nitric oxide synthase activity by using substituted indole compound |
| 07/06/2005 | CN1635881A Liquid formulation of metformin |
| 07/06/2005 | CN1635880A Use of biguanide derivatives for making a medicine having a wound healing effect |
| 07/06/2005 | CN1635878A Methods of treating cancer and the pain associated therewith with using endothelin antagonists |
| 07/06/2005 | CN1635874A Method of treating metabolic disorders, especially diabetes, or a disease or condition associated with diabetes |
| 07/06/2005 | CN1635832A Method for administering GLP-1 molecules |
| 07/06/2005 | CN1634996A Polyporus albicans polysaccharide, its preparing process and pharmaceutical composition using the compound as active component |
| 07/06/2005 | CN1634953A Medicament for treating diabetes, diabetes complication, its preparation and novel use |
| 07/06/2005 | CN1634885A Novel mitiglinide crystalline form and its preparing process |
| 07/06/2005 | CN1634857A Fenfluramine hydrochloride raw material drug and its preparing method |
| 07/06/2005 | CN1634546A Health food prepared by spirulina, its extracts and traditional Chinese medicine and Tibet medicine |
| 07/06/2005 | CN1634530A Modified Huoxiang Zhengqi drop pill and its preparation method |
| 07/06/2005 | CN1634526A Health-care food for regulating blood sugar |
| 07/06/2005 | CN1634496A Chinese traditional medicine composition for treating diabetes and preparation method thereof |
| 07/06/2005 | CN1634487A Dripping pills for treating high blood fat and its preparing method |
| 07/06/2005 | CN1634463A Medicine for treating diabetes and production method thereof |
| 07/06/2005 | CN1634420A Gynostemma pentaphylla general glycoside soft capsule and preparation method thereof |
| 07/06/2005 | CN1634414A Curcuma aromatica freeze dried and preparation method thereof |